UniSuper Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Sell
8,577
-62
-0.7% -$47.5K 0.04% 206
2025
Q4
$6.67M Sell
8,639
-920
-10% -$625K 0.04% 205
2025
Q3
$5.37M Buy
9,559
+1,191
+14% +$673K 0.03% 262
2025
Q2
$4.39M Buy
8,368
+566
+7% +$316K 0.03% 271
2025
Q1
$4.95M Buy
7,802
+496
+7% +$341K 0.04% 228
2024
Q4
$5.2M Buy
7,306
+2,013
+38% +$1.69M 0.04% 219
2024
Q3
$5.56M Buy
5,293
+144
+3% +$160K 0.04% 214
2024
Q2
$5.41M Buy
5,149
+2,740
+114% +$2.66M 0.04% 204
2024
Q1
$2.32M Buy
2,409
+1,530
+174% +$1.45M 0.02% 231
2023
Q4
$772K Sell
879
-757
-46% -$623K 0.01% 285
2023
Q3
$1.35M Sell
1,636
-198
-11% -$156K 0.02% 246
2023
Q2
$1.32M Buy
+1,834
New +$1.41M 0.02% 251

Other funds holding REGN